Investing
Three Biotechs Join Stocks Under $10 Watch List
03/12/08 - 07:09 AM EDT
One of the names that we recommend investors keep an eye on is Seattle Genetics SGEN, which has a strong research platform and attractive pipeline candidates that are concentrated in cancer therapies. Another potential winner is Dynavax TechnologiesDVAX, a San Francisco-based biotech that focuses on drugs aimed at improving the body's immune response to hepatitis, cancer and even ragweed allergies. A final play we view as having a reduced-risk profile is DurectDRRX, which uses its proprietary drug delivery technologies to improve existing pain-relief drug ingredients such as oxycodone. We will keep you updated on these three biotech stocks and more names as they appear on our watch list, for the Stocks Under $10 model portfolio. Seattle Genetics, Dynavax Technologies and Durect are on the Watch List for TheStreet.com Stocks Under $10 model portfolio. Frank Curzio and Larsen Kusick write regularly on stocks priced under $10 a share, such as PolyOnePOL, UnisysUIS and MotorolaMOT for TheStreet.com.
Bears have the upper hand here, but they need to pay attention to bullish cases.
Based on the overwhelming pessimism, my short-term market outlook is more bullish.
Inroads in China and India cinema are helping diversify this Breakout Stocks' holding's revenue stream.
These forgotten Internet stocks are being accumulated by hedge funds.
Raspberries for Apple; You'll be sorry, UBS; Fortress or Fort Knox? Wholly unappetizing Foods; give Liberty AOL or give them...
The GOP presidential candidate raised $27 million in July.
Some credit and debit cards give you some cash back on purchases. But you need to manage it well to benefit from it.
Sponsored by:





